Cancer Today's 2025 summer issue covers the expanded use of neoadjuvant immunotherapy, PSMA-targeted therapy for prostate cancer, and more.
At the AACR Annual Meeting 2025, researchers and patient advocates shared insights into the impact of NIH funding cuts...